Status:
COMPLETED
Infections and Colonization With the Third Group of Enterobacteriaceae in the Intensive Care Unit
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Critically Ill
Enterobacteriaceae Infections
Eligibility:
All Genders
18+ years
Brief Summary
There is a lack of data whether colonization and infection with Enterobacteriaceae of the third group (EB3) affect the outcomes for ICU patients. This study evaluated the effects of EB3 colonization a...
Eligibility Criteria
Inclusion
- adults critically ill patients admitted to the the participating ICUs during the study period
- with colonization and/or infection with a third group enterobacteriacea
- and with a lenght of stay \> 24h
Exclusion
- minors patients
- lenght of stay \< 24h
Key Trial Info
Start Date :
April 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
179 Patients enrolled
Trial Details
Trial ID
NCT04528043
Start Date
April 1 2017
End Date
December 31 2019
Last Update
August 27 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Emmanuel NOVY
Vandœuvre-lès-Nancy, Lorraine, France, 54500